BMJ  2003;326:1115 (24 May), doi:10.1136/bmj.326.7399.1115

Paper

Stepping down inhaled corticosteroids in asthma: randomised controlled trial

Gillian Hawkins, clinical research fellow1, Alex D McMahon, senior statistician2, Sara Twaddle, head of research and development3, Stuart F Wood, senior lecturer1, Ian Ford, professor2, Neil C Thomson, professor4

1 Department of General Practice, University of Glasgow, Glasgow G12 0RR, 2 Robertson Centre for Biostatistics, University of Glasgow, Glasgow G12 8QQ, 3 Department of Research and Development, Stobhill Hospital, Glasgow G21 3UT, 4 Department of Respiratory Medicine, University of Glasgow, Western Infirmary, Glasgow G11 6NT

Correspondence to: N C Thomson n.c.thomson{at}clinmed.gla.ac.uk

Objectives To determine whether the dose of inhaled corticosteroids can be stepped down in patients with chronic stable asthma while maintaining control. Design One year, randomised controlled, double blind, parallel group trial.

Setting General practices throughout western and central Scotland.

Participants 259 adult patients with asthma receiving regular treatment with inhaled corticosteroids at high dose (mean dose 1430 µg beclomethasone dipropionate).

Interventions Participants were allocated to receive either no alteration to their dose of inhaled corticosteroid (control) or a 50% reduction in their dose if they met criteria for stable asthma (stepdown).

Main outcome measures Comparison of asthma exacerbation rates, asthma related visits to general practice and hospital, health status measures, and corticosteroid dosage between the two groups.

Results The proportions of subjects with asthma exacerbations were not significantly different (stepdown 31%, control 26%, P=0.354). Similarly, the numbers of visits to general practice or hospital and the disease specific and generic measures of health status over the one year period were not significantly different. On average the stepdown group received 348 µg (95% confidence interval 202 µgto494 µg) of beclomethasone dipropionate less per day than the controls (a difference of 25%), with no difference in the annual dose of oral corticosteroids between the two treatment regimens.

Conclusions By adopting a stepdown approach to the use of inhaled steroids at high doses in asthma a reduction in the dose can be achieved without compromising asthma control.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Article

Patients with stable asthma may be able to take less inhaled corticosteroid
BMJ 2003 326: 0. [Full Text]

This article has been cited by other articles:

  • Reddel, H. K., Taylor, D. R., Bateman, E. D., Boulet, L.-P., Boushey, H. A., Busse, W. W., Casale, T. B., Chanez, P., Enright, P. L., Gibson, P. G., de Jongste, J. C., Kerstjens, H. A. M., Lazarus, S. C., Levy, M. L., O'Byrne, P. M., Partridge, M. R., Pavord, I. D., Sears, M. R., Sterk, P. J., Stoloff, S. W., Sullivan, S. D., Szefler, S. J., Thomas, M. D., Wenzel, S. E., on behalf of the American Thoracic Society/Europea, (2009). An Official American Thoracic Society/European Respiratory Society Statement: Asthma Control and Exacerbations: Standardizing Endpoints for Clinical Asthma Trials and Clinical Practice. Am. J. Respir. Crit. Care Med. 180: 59-99 [Abstract] [Full text]  
  • Papi, A., Caramori, G., Adcock, I. M., Barnes, P. J. (2009). Rescue Treatment in Asthma: More Than As-Needed Bronchodilation. Chest 135: 1628-1633 [Abstract] [Full text]  
  • Turner, S, Thomas, M, von Ziegenweidt, J, Price, D (2009). Prescribing trends in asthma: a longitudinal observational study. Arch. Dis. Child. 94: 16-22 [Abstract] [Full text]  
  • Lucas, A., Smeenk, F., Smeele, I., van Schayck, C. (2008). Overtreatment with inhaled corticosteroids and diagnostic problems in primary care patients, an exploratory study. Fam Pract 25: 86-91 [Abstract] [Full text]  
  • Bateman, E. D., Hurd, S. S., Barnes, P. J., Bousquet, J., Drazen, J. M., FitzGerald, M., Gibson, P., Ohta, K., O'Byrne, P., Pedersen, S. E., Pizzichini, E., Sullivan, S. D., Wenzel, S. E., Zar, H. J. (2008). Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 31: 143-178 [Abstract] [Full text]  
  • Black, P. N., Chen, R., Zitt, M. J., Rachelefsky, G. S., Peters, S. P., Castro, M., Holbrook, J. T. (2007). Reducing Asthma Treatment. NEJM 357: 504-506 [Full text]  
  • Diette, G. B., Patino, C. M., Merriman, B., Paulin, L., Riekert, K., Okelo, S., Thompson, K., Krishnan, J. A., Quartey, R., Perez-Williams, D., Rand, C. (2007). Patient Factors That Physicians Use to Assign Asthma Treatment. Arch Intern Med 167: 1360-1366 [Abstract] [Full text]  
  • FitzGerald, J M, Gibson, P G (2006). Asthma exacerbations {middle dot} 4: Prevention.. Thorax 61: 992-999 [Abstract] [Full text]  
  • Paton, J, Jardine, E, McNeill, E, Beaton, S, Galloway, P, Young, D, Donaldson, M (2006). Adrenal responses to low dose synthetic ACTH (Synacthen) in children receiving high dose inhaled fluticasone. Arch. Dis. Child. 91: 808-813 [Abstract] [Full text]  
  • Bruton, A, Thomas, M (2006). Breathing therapies and bronchodilator use in asthma.. Thorax 61: 643-645 [Full text]  
  • Slader, C A, Reddel, H K, Spencer, L M, Belousova, E G, Armour, C L, Bosnic-Anticevich, S Z, Thien, F C K, Jenkins, C R (2006). Double blind randomised controlled trial of two different breathing techniques in the management of asthma. Thorax 61: 651-656 [Abstract] [Full text]  
  • Smith, A. D., Cowan, J. O., Brassett, K. P., Herbison, G. P., Taylor, D. R. (2005). Use of Exhaled Nitric Oxide Measurements to Guide Treatment in Chronic Asthma. NEJM 352: 2163-2173 [Abstract] [Full text]  
  • Deykin, A. (2005). Targeting Biologic Markers in Asthma -- Is Exhaled Nitric Oxide the Bull's-Eye?. NEJM 352: 2233-2235 [Full text]  
  • Reddel, H.K. (2004). Goals of asthma treatment: how high should we go?. Eur Respir J 24: 715-717 [Full text]  
  • Barnes, N. C. (2004). Can Guideline-defined Asthma Control Be Achieved?: The Gaining Optimal Asthma Control Study. Am. J. Respir. Crit. Care Med. 170: 830-831 [Full text]  
  • Partridge, M R (2004). Written asthma action plans. Thorax 59: 87-88 [Full text]  
  • Peters, J. I (2004). Inhaled corticosteroids were safely stepped down in chronic, stable asthma. Evid. Based Med. 9: 16-16 [Full text]  
  • (2004). Other articles noted: 25 Jul 03 to 7 Nov 03. Evid. Based Nurs. 7: e1-1 [Full text]  
  • (2003). Selections from Journal Watch Pediatrics and Adolescent Medicine. Arch. Dis. Child. 88: 943-944 [Full text]  
  • (2003). Corticosteroids in Asthma: Is Less More?. JWatch Pediatrics 2003: 10-10 [Full text]  
  • (2003). Reducing the Dose of Inhaled Steroids in Asthma. JWatch General 2003: 3-3 [Full text]  

Rapid Responses:

Read all Rapid Responses

Alternatives to Inhalers
Sharon J Williams
bmj.com, 23 May 2003 [Full text]
Asthma diagnosis
Olle Löwhagen, et al.
bmj.com, 29 May 2003 [Full text]
Another alternative
Frank J Leavitt
bmj.com, 29 May 2003 [Full text]
The impact of illustrations must be considered
Jane C Davies
bmj.com, 4 Jun 2003 [Full text]
Further to my response
Frank J Leavitt
bmj.com, 5 Jun 2003 [Full text]
Evidence of equivalence rather than difference
Nick Freemantle
bmj.com, 18 Jun 2003 [Full text]



Access jobs at BMJ Careers
Whats new online at Student 

BMJ